Lyell Immunopharma (LYEL) Revenue (2020 - 2026)
Lyell Immunopharma (LYEL) recorded Revenue of $4,000 in Q2 2026, down 50.0% from $8,000 a year earlier but up 100.0% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Revenue (2020 - 2026) Analysis & Trends
On a TTM basis, Lyell Immunopharma's Revenue came in at $27,000 as of Jun 30, 2026, down 55.0% year-over-year; for FY2025, it was $36,000, down 41.0% from FY2024.
- Annual Revenue has declined for three straight years, with a five-year compound annual growth rate of -65.9% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $61,000 in FY2024 (-53.1%), $130,000 in FY2023 (-99.8%), $84.68 million in FY2022 (+695.1%) and $10.65 million in FY2021 (+37.3%).
- Quarterly Revenue has ranged from $2,000 in Q1 2026 to $48.39 million in Q4 2022 over the past five years.
- On a year-over-year basis, Revenue has declined for five consecutive quarters, with an average decline of 13.4% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 733.3% in Q3 2023, against a decline of 100.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2,000 (Q1 2026), $6,000 (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Lyell Immunopharma | 229.06 Mn | 229.06 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 48.39 Mn |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.76 Mn |
API Access
Lyell Immunopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();